Brain

Brainomix Driving Treatment Decisions in Stroke: New Studies Presented at Leading European Stroke ConferenceBrainomix Driving Treatment Decisions in Stroke: New Studies Presented at Leading European Stroke Conference

Brainomix Driving Treatment Decisions in Stroke: New Studies Presented at Leading European Stroke Conference

New evidence from the largest prospective evaluation of stroke AI imaging further validates Brainomix 360 Stroke impact on mechanical thrombectomy,…

1 month ago
BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinicBioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic

BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic

IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102 induced weight loss in preclinical…

1 month ago
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani ShareholdersVivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders

Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders

Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for Vivani…

1 month ago
LandingAI Launches Agentic Document Extraction for Unlocking Insights from Complex DocumentsLandingAI Launches Agentic Document Extraction for Unlocking Insights from Complex Documents

LandingAI Launches Agentic Document Extraction for Unlocking Insights from Complex Documents

Transforming Enterprises Complex Document Workflows and Understanding with Agentic Vision Technologies PALO ALTO, Calif., May 28, 2025 /PRNewswire/ -- LandingAI,…

1 month ago
Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer CanadaImmunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada

Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada

TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is proud to award $85,000 to a groundbreaking research project…

1 month ago
Achieve Life Sciences to Present at the Jefferies Global Healthcare ConferenceAchieve Life Sciences to Present at the Jefferies Global Healthcare Conference

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty…

1 month ago
DentScribe CoPilot Launches AI That Turns SOAP Notes into a Real-Time Dental Care Checklist, Now Live for Every PracticeDentScribe CoPilot Launches AI That Turns SOAP Notes into a Real-Time Dental Care Checklist, Now Live for Every Practice

DentScribe CoPilot Launches AI That Turns SOAP Notes into a Real-Time Dental Care Checklist, Now Live for Every Practice

SUNNYVALE, Calif., May 28, 2025 /PRNewswire/ -- Imagine starting every dental appointment with an AI-generated checklist built just for your…

1 month ago
CEFALY Technology Introduces CEFALY@Work: A Workplace Wellness Initiative for Employees With MigraineCEFALY Technology Introduces CEFALY@Work: A Workplace Wellness Initiative for Employees With Migraine

CEFALY Technology Introduces CEFALY@Work: A Workplace Wellness Initiative for Employees With Migraine

DARIEN, Conn., May 27, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology today announced the launch of CEFALY@Work, a new offering…

1 month ago
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual MeetingVaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting

Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting

Neoadjuvant treatment with pepinemab appears to induce abundant, mature lymphoid structures that correlate with improved pathologic response.ROCHESTER, N.Y., May 27,…

1 month ago